Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses

NCT05674825 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Targeted agent
DRUG: Standard of care agent

Sponsor

Medical College of Wisconsin